After being off the marked for over a year, the branded medication Levoxyl (levothyroxine sodium) is expected to be available in pharmacies on approximately March 3, 2014, according to a statement released by Pfizer. The medication is approved to treat hypothyroidism and various types of euthyroid goiters.